Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
BIOCON
₹418.25
₹404.00
₹419.80
₹331.00
₹440.40
Markets Today
Historical Performance
As of 10-07-2026 19:37, Biocon Ltd. share price today is ₹0, with a change of ₹-403.55 (-100.00%) from the previous close of ₹403.55. The stock opened at ₹407.2 and traded between ₹404 and ₹419.8, with a total traded volume of 4324350 shares. The company has a market capitalization of ₹65766.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹440.4 and ₹331, respectively.
Biocon Ltd. valuation metrics include a P/E ratio of 170.6, EPS of ₹2.82, and book value of ₹1.90. Profitability indicators show ROE of 1.13% along with a dividend yield of 0.1%. Biocon Ltd. has reported revenue of ₹16927 Cr and net profit of ₹385.6 Cr.
Biocon Ltd. technical indicators include Day RSI at 42, Day MFI at 64.81, Day ADX at 15.46. Additional indicators include Commodity Channel Index (CCI) at -210.4 and Williams %R at -76.68. Momentum indicators show Day MACD at -0.74, Day MACD Signal Line at 1.84, DayATR at 11.56. Rate of Change indicators for Biocon Ltd. include ROC125 at 2.7 and ROC21 at -3.07.
Exponential moving averages include EMA5 at ₹408.1, EMA10 at ₹412.2, EMA12 at ₹413, EMA20 at ₹414.2, EMA26 at ₹413.8, EMA50 at ₹407.9, EMA100 at ₹397.7, EMA200 at ₹386.2. Simple moving averages include SMA5 at ₹411.7, SMA10 at ₹414.5, SMA20 at ₹415.9, SMA30 at ₹416.8, SMA50 at ₹410.7, SMA100 at ₹391.4, SMA150 at ₹388.5, SMA200 at ₹384.3.
Support levels for Biocon are placed at First Support ₹395.73, Second Support ₹387.92, Third Support ₹380.98. Resistance levels are seen at First Resistance ₹410.48, Second Resistance ₹417.42, Third Resistance ₹425.23. Biocon Ltd. shareholding pattern shows promoter holding at 44.91%, FII holding at 7.52%, DII holding at 0%, public holding at 23.4%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 604.70 | 621.30 | 583.30 | 537.10 | 643.80 |
| Operating Expense | 525.40 | 548 | 530.40 | 516.50 | 581.80 |
| Operating Profit | 79.30 | 73.30 | 52.90 | 20.60 | 62 |
| Depreciation | 36.20 | 34 | 33.80 | 33.30 | 33 |
| Interest | 16.70 | 2.30 | 67.20 | 56.20 | 56.70 |
| Tax | 6.40 | -8.10 | 14.80 | 0.70 | 13.80 |
| Net Profit | 51 | -76.40 | 70.90 | -8.30 | 21.20 |
₹418.25
↗ Bullish Moving Average
5
↘ Bearish Moving Average
11
\
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 60.6 | 60.6 | 54.4 | 54.4 | 54.4 | 44.9 |
| FII | 5.7 | 5.7 | 6 | 6.6 | 7.4 | 7.5 |
| DII | 15.3 | 15.7 | 22.9 | 22.1 | 21.7 | 24.1 |
| Public | 18.1 | 17.8 | 16.5 | 16.7 | 16.3 | 23.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 25.18 L | 57.89 L | 43.50% |
| Week | 22.1 L | 45.7 L | 48.36% |
| 1 Month | 19.64 L | 38.63 L | 50.85% |
| 6 Month | 20.11 L | 41.02 L | 49.03% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
PEG lower than Industry PEG
Companies with Low Debt
Companies with reducing Debt
Companies with Zero Promoter Pledge
Top Gainers
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 03 Jul, 2026 | 0.5 | FINAL | 03 Jul, 2026 | Equity Share |
| 04 Jul, 2025 | 0.5 | FINAL | 04 Jul, 2025 | Equity Share |
| 05 Jul, 2024 | 0.5 | FINAL | 05 Jul, 2024 | Equity Share |
| 07 Jul, 2023 | 1.5 | FINAL | 07 Jul, 2023 | Equity Share |
| 30 Jun, 2022 | 0.5 | FINAL | 01 Jul, 2022 | Equity Share |
| 18 Jul, 2019 | 0.5 | FINAL | 19 Jul, 2019 | Equity Share |
| 19 Jul, 2018 | 1 | FINAL | 20 Jul, 2018 | Equity Share |
| 20 Jul, 2017 | 1 | FINAL | Equity Share | |
| 17 Mar, 2016 | 5 | INTERIM | 19 Mar, 2016 | Equity Share |
| 09 Apr, 2015 | 5 | INTERIM | 10 Apr, 2015 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,429 | ₹754.95 | ₹1,568.90 | ₹1,932.90 | ₹19,478 | ₹1,780.10 |
| % Change | 1.55% | 0.39% | -1.17% | -0.30% | -0.33% | 0.55% |
| Revenue TTM (₹ Cr) | ₹1,753.96 | ₹2,124.33 | ₹33,653.08 | ₹58,462.04 | ₹2,022.99 | ₹9,646.33 |
| Net Profit TTM (₹ Cr) | ₹246.74 | ₹591.79 | ₹3,732.47 | ₹11,479.42 | ₹364 | ₹1,141.12 |
| PE TTM | 94.30 | 71.60 | 24.70 | 40.50 | 68.90 | 39.40 |
| 1 Year Return | 190.14 | 31.93 | 38.93 | 16.13 | 63.29 | 21.64 |
| ROCE | 24.32 | 27.56 | 13.73 | 19.45 | 23.10 | 17.23 |
J B Chemicals & Pharmaceuticals Ltd.
₹ 2420.00
-1.00%
AstraZeneca Pharma India Ltd.
₹ 8115.00
+0.01%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2433.00
-0.30%
Pfizer Ltd.
₹ 4720.00
+2.83%
Abbott India Ltd.
₹ 27340.00
+2.13%
Torrent Pharmaceuticals Ltd.
₹ 4890.00
-0.17%
Lupin Ltd.
₹ 2496.00
-0.29%
Dr. Reddy's Laboratories Ltd.
₹ 1246.90
-1.78%
Cipla Ltd.
₹ 1442.00
+0.05%
Sai Life Science Ltd.
₹ 1265.00
+2.48%
Emcure Pharmaceuticals Ltd.
₹ 1805.00
-0.25%
Mankind Pharma Ltd.
₹ 2523.00
-0.36%
Piramal Pharma Ltd.
₹ 176.50
+2.62%
Acutaas Chemicals Ltd.
₹ 3390.00
-1.99%
Gland Pharma Ltd.
₹ 2475.00
+0.22%
Laurus Labs Ltd.
₹ 1535.50
+1.86%
Alkem Laboratories Ltd.
₹ 5676.00
+0.49%
Divi's Laboratories Ltd.
₹ 6830.50
+0.26%
Granules India Ltd.
₹ 887.00
+0.56%
Ajanta Pharma Ltd.
₹ 3366.00
+1.77%
Zydus Lifesciences Ltd.
₹ 1152.10
-0.60%
Glenmark Pharmaceuticals Ltd.
₹ 2284.50
+0.76%
Wockhardt Ltd.
₹ 1812.80
-1.01%
By signing up I certify terms, conditions & privacy policy